Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Potential tissue-imaging agents: 23-(trimethyl (117mSn)stannyl)-24-nor-5 alpha-cholan-3 beta-ol

Journal Article · · J. Med. Chem.; (United States)
DOI:https://doi.org/10.1021/jm00364a034· OSTI ID:6826778

Tin-117m-labeled 23-(trimethylstannyl)-24-nor-5 alpha-cholan-3 beta-ol (2) has been prepared by reaction of trimethyl (117mSn)tin lithium with 3 beta-acetoxy-23-bromo-24-nor-5 alpha-cholane (1). Tin-117m (2) shows pronounced adrenal uptake (2.5% injected dose) in female rats 1 day after injection. Furthermore, the adrenal to liver (9.1:1) and adrenal to blood (33.7:1) ratios are high after this period. The absorbed radiation dose values from (117mSn)2 to human organs have also been estimated by using rat tissue distribution and excretion data. (117mSn)2 is the first reported tissue-specific organic radiopharmaceutical labeled with this nuclide and may have potential as an adrenal imaging agent.

OSTI ID:
6826778
Journal Information:
J. Med. Chem.; (United States), Journal Name: J. Med. Chem.; (United States) Vol. 26:10; ISSN JMCMA
Country of Publication:
United States
Language:
English